Antiviral activities of nucleotide heterodimers against human immunodeficiency virus type 1 in vitro

This publication has 17 references indexed in Scilit:

• Preclinical evaluation of MKC-442, a highly potent and specific inhibitor of human immunodeficiency virus type 1 in vitro
  Antimicrobial Agents and Chemotherapy, 1994
• Review of HIV-1 reverse transcriptase three-dimensional structure: Implications for drug design
  Perspectives in Drug Discovery and Design, 1993
• Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.
  Journal of Clinical Investigation, 1993
• Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine
  Antimicrobial Agents and Chemotherapy, 1993
• Nucleotidic prodrugs of anti-HIV dideoxynucleosides
  Bioorganic & Medicinal Chemistry Letters, 1992
• Decreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDS
  The Journal of Infectious Diseases, 1990
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989
• Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
  Journal of Virological Methods, 1988
• Nucleotide Dimers Suppress HIV Expression In Vitro
  AIDS Research and Human Retroviruses, 1988
• Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro
  Antimicrobial Agents and Chemotherapy, 1987